Nα-terminal (Nt-) acetylation is a ubiquitous and evolutionarily conserved post-translational modification in eukaryotic cells, occurring either co- or post-translationally in the majority of cellular proteins. This modification influences protein folding, stability, turnover, subcellular localization, and molecular interactions (Calis and Gevaert, 2025, McTiernan et al., 2025).
The N-degron pathways, formerly known as the N-end rule pathways, are conserved proteolytic systems that regulate protein degradation by recognizing specific Nt-residues as degradation signals (N-degrons) (Heo et al., 2023, Varshavsky, 2024). Among these, the Ac/N-degron pathway selectively targets Nt-acetylated proteins, using their acetylated N-termini as degradation signals (Ac/N-degrons) for polyubiquitylation-mediated proteasomal degradation (Hwang et al., 2010, Nguyen et al., 2018, Yang and Hwang, 2024).
MARCHF6, an endoplasmic reticulum (ER)-transmembrane E3 ubiquitin (Ub) ligase, serves as the principal Ac/N-recognin of the Ac/N-degron pathway (Varshavsky, 2024, Yang et al., 2023). This multi-spanning transmembrane enzyme consists of 14 transmembrane helices and eight cytosolic regions, including an N-terminal catalytic RING domain and a NADPH-sensing C-terminal regulatory MRR domain (Nguyen et al., 2022, Yang et al., 2023). MARCHF6 mediates the degradation of Ac/N-degron-bearing substrates such as the G-protein regulator RGS2 and the lipid droplet-associated protein PLIN2 (Nguyen et al., 2019, Park et al., 2015). Additionally, MARCHF6 targets, for degradation, non-Ac/N-degron-bearing proteins such as the tumor suppressor p53, the long-chain acyl-CoA synthase ACSL4, and cytosolically mislocalized proopiomelanocortin (POMC)—thereby modulating ferroptosis, an iron-dependent lipid peroxidation-driven mode of regulated cell death (Berndt et al., 2024, Mun and Hwang, 2024, Mun et al., 2023, Nguyen et al., 2022, Yang et al., 2024). MARCHF6 also regulates cholesterol homeostasis by degrading squalene monooxygenase, independent of Nt-acetylation (Scott et al., 2021, Yang et al., 2024).
Despite significant progress in defining the molecular architecture and cellular functions of MARCHF6 and its orthologs, yeast Doa10 and plant Doa10-like proteins (Botsch et al., 2024, Etherington et al., 2023, Mehrtash and Hochstrasser, 2022, Wu et al., 2024), the precise molecular determinants governing Ac/N-degron recognition remain unclear. This knowledge gap stems from several challenges: (1) the inherent biochemical complexity of ER-resident transmembrane proteins, (2) limited structural information on the cytosol-facing unstructured regions of MARCHF6, and (3) the intricate interplay between Ac/N-degrons and non-Ac/N-degrons, which may function either exclusively or cooperatively depending on the Nt-acetylation status of the target protein (Scott et al., 2021, Yang and Hwang, 2024, Yang et al., 2024). Resolving these questions is critical for advancing our understanding of the Ac/N-degron pathway and its broader implications in proteostasis regulation.
Given that Nt-acetylation predominantly occurs in the cytosol (Calis and Gevaert, 2025, McTiernan et al., 2025), we hypothesized that MARCHF6 recognizes Ac/N-degron substrates through a cytosol-facing domain. To systematically identify this domain, we employed two complementary approaches: (1) alanine-scanning mutagenesis targeting evolutionarily conserved residues within the cytosolic domains of MARCHF6, followed by biochemical analyses using chemical crosslinking and co-immunoprecipitation (Co-IP); and (2) split-ubiquitin (Split-Ub) assays with truncated MARCHF6 fragments and isolated cytosolic domains to delineate the Ac/N-degron recognition region (Fig. 1) (Yang et al., 2024). Through these methodologies, we aimed to define the Ac/N-domain within MARCHF6, providing mechanistic insights into its role in regulated protein degradation and its rheostatic function in ferroptosis (Yang et al., 2024). The subsequent sections detail the methodologies employed in this study.